Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Connective tissue disorder, Foreign body sensation in eyes, Ocular hyperaemia, Pain in extremity, Photophobia
Clinical narrative: runny nose; red irritated eye; Mild swollen eyelid; light sensitivity; gritty feeling in eyes; flare up of connective tissue disorder; Severe sore left arm; Swelling injection site; This spontaneous case was reported by a nurse and describes the occurrence of RHINORRHOEA (runny nose), OCULAR HYPERAEMIA (red irritated eye), SWELLING OF EYELID (Mild swollen eyelid), PHOTOPHOBIA (light sensitivity) and FOREIGN BODY SENSATION IN EYES (gritty feeling in eyes) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026C21A and 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hay fever, Hives and Stroke in 2020. Previously administered products included for an unreported indication: FLU VACCINE VII (severe flu-like symptoms x 2wks (cough, fever, tearing and sore throat)) in 1970. Concurrent medical conditions included Hypersensitivity, Asthma, Drug allergy (History GI Bleeding, Diverticulitis, GERD's), Drug allergy (Itching, rash, hypersensitivity altered mental status, easily agitated), Drug allergy (Itching, rash, hypersensitivity altered mental status, easily agitated), Drug allergy (Rash, Itching, Cough), Lymphoma (non-Hodgkin's) (Remains in Remission) since 16-Aug-2013, Hypertension (Controlled) since 1995, Diabetic peripheral neuropathy (Controlled) since 1970, Glaucoma (intraocular stints & cataract IOL. Severe FB sensation, photo sensitivity, tearing, lid swelling since COVID-19 vaccination) since 1995, Connective tissue disorder (Intermittent flare ups last occurrence April and May 2021) since 2018, Drug allergy (Rash, Itching, Cough) and Drug allergy (Rash, itching with both medications). Concomitant products included GABAPENTIN (GABAPENTIN "PCD") from 1995 to an unknown date for Diabetic peripheral neuropathy, PANTOPRAZOLE SODIUM from 1995 to an unknown date for GERD, METOPROLOL TARTRATE (METOPROLOL TARTRATE ACCORD) from 2020 to an unknown date for Heart rate irregular, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HCTZ) from 1995 to an unknown date and AMLODIPINE BESILATE (AMLODIPINE [AMLODIPINE BESILATE]) from 2020 to an unknown date for Hypertension.   On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021 at 1:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-May-2021, the patient experienced RHINORRHOEA (runny nose), OCULAR HYPERAEMIA (red irritated eye), SWELLING OF EYELID (Mild swollen eyelid), PHOTOPHOBIA (light sensitivity), FOREIGN BODY SENSATION IN EYES (gritty feeling in eyes), CONNECTIVE TISSUE DISORDER (flare up of connective tissue disorder), PAIN IN EXTREMITY (Severe sore left arm) and VACCINATION SITE SWELLING (Swelling injection site). The patient was treated with LOTEPREDNOL ETABONATE (LOTEMAX SM) (ophthalmic) from 19-May-2021 to 20-May-2021 for Adverse event, at a dose of UNK, bid - qid. On 20-May-2021, RHINORRHOEA (runny nose), OCULAR HYPERAEMIA (red irritated eye), SWELLING OF EYELID (Mild swollen eyelid), PHOTOPHOBIA (light sensitivity), FOREIGN BODY SENSATION IN EYES (gritty feeling in eyes), CONNECTIVE TISSUE DISORDER (flare up of connective tissue disorder), PAIN IN EXTREMITY (Severe sore left arm) and VACCINATION SITE SWELLING (Swelling injection site) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other treatment medication included steroids.   This case was linked to MOD-2021-090377.